Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03035500 · ClinicalTrials.gov registry record · NA

Long-Term Follow-Up in Patients With Prostate Cancer After Surgery

A NA study of Prostate Carcinoma and Cancer Survivor, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
2,500
Enrollment target
1
Study location

NCT03035500: Active NA study of Prostate Carcinoma and Cancer Survivor, sponsored by City of Hope Medical Center.

NCT03035500 is a NA study of Prostate Carcinoma and Cancer Survivor that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 2,500 participants, above the 1,459-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03035500, a NA study of Prostate Carcinoma and Cancer Survivor, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
2,500 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies how well a long-term follow-up works in patients with prostate cancer after surgery. Long-term follow-up data may serve as a resource to help ask clinical questions, describe health-related quality of life and long-term complications related, and facilitate future studies focusing on interventions to improve health status and health-related quality of life in prostate cancer survivors.

Primary Outcome

Linear mixed effects models can be used to estimate long-term trends and examine the effects of baseline and concomitant factors on these trends.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Laboratory Biomarker Analysis
  • OTHER Questionnaire Administration
  • OTHER Educational Intervention
  • OTHER Long-term Follow-up

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2008-07-23
Est. Completion 2026-07-28
Phase NA
City of Hope Medical Center

582 total trials

What the registry record for NCT03035500 still lists

NCT03035500 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,459-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (71% higher).

The record links to 2 conditions, with Prostate Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03035500 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03035500 about?

NCT03035500 is a clinical study titled "Long-Term Follow-Up in Patients With Prostate Cancer After Surgery". This clinical trial studies how well a long-term follow-up works in patients with prostate cancer after surgery. Long-term follow-up data may serve as a resource to help ask clinical questions, describe health-related quality of life and long-term complications related, and facilitate future studies...

What is the current status of trial NCT03035500?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2008-07-23. Estimated completion is 2026-07-28.

What conditions does trial NCT03035500 study?

This clinical trial studies the following conditions: Prostate Carcinoma, Cancer Survivor.

What interventions are being tested in trial NCT03035500?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Educational Intervention (OTHER), Long-term Follow-up (OTHER).

Who is sponsoring clinical trial NCT03035500?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03035500 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03035500's enrollment target sits among peer trials

2,500 2nd of 59 the highest of 59 other Prostate Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03035500, the US trial registry maintained by the National Library of Medicine. NCT03035500 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.